Return to content in this issue
Successful Desensitization to Ramucirumab in Signet-Cell Gastric Adenocarcinoma
Villarreal-González RV1,2, Madrazo-Morales M1, Sáenz-Cantú KS1, García Rosas C3, Burguete-Torres A1,2, Vidal-Gutiérrez O1,2
1Oncology Service, Centro Universitario Contra el Cáncer (CUCC), Hospital Universitario “Dr. José Eleuterio González”, Monterrey, Nuevo León, México
2Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
3Hospital General de Ensenada, Baja California, México
J Investig Allergol Clin Immunol 2025; Vol. 35(4)
doi: 10.18176/jiaci.1066
Key words: Anaphylaxis, Desensitization, Hypersensitivity reactions, Ramucirumab